Awards

Croce is Recipient of International Carcinogenesis Award
 
Carlo Croce, MD, director of Human Cancer Genetics at Ohio State, where he also chairs the Department of Molecular Virology, Immunology and Medical Genetics, received the 2012 Anthony Dipple Carcinogenesis Award at the 22nd meeting of the European Association for Cancer Research in Barcelona, Spain. The award, sponsored by Oxford University Press, is given to individuals who have made major contributions to research in carcinogenesis. Croce also is a member of the Institute of Medicine of the National Academies, the National Academy of Sciences of the United States, and the Accademia Nazionale delle Scienze detta dei XL in Italy. He is principal investigator on 11federal research grants and has published more than 900 peer-reviewed research papers.

 
Gillison Lands Rosenthal Memorial Award for HPV Work in Cancer
 
Maura Gillison, MD, PhD, a member of the Cancer Control and Viral Oncology programs at the OSUCCC – James, received the 36th Annual Richard and Hinda Rosenthal Memorial Award from the American Association for Cancer Research(AACR). Gillison accepted the award at the AACR’s annual meeting in Chicago. The award recognizes her contributions to understanding the role of human papillomavirus(HPV) in head and neck cancers. As recipient, Gillison presented “Clinical Implications of HPV in Head and Neck Cancers” at the annual meeting.


Caligiuri Elected Vice President of Society for Natural Immunity
 
Michael A. Caligiuri, MD, director of the OSUCCC and CEO of The James, was elected vice president of the Society for Natural Immunity (SNI) in April 2012 at its13th  meeting. Caligiuri will serve in that capacity for three years and then become president for another three years. SNI meets every 18 months at sites around the world so investigators and trainees can hear about recent findings in the field of natural immunity. The focus is on natural killer (NK) cells, but related fields are included. The sessions blend basic science with clinical studies and advances.

http://journals.lww.com/oncology-times/Fulltext/2012/09100/SHOP_TALK__Appointments,_Promotions,_Honors,.17.aspx

 
 
OSUCCC – James Researchers Gain Multiple Honors at Alliance for Clinical Trials in Oncology Meeting
 
Three renowned researchers at the OSUCCC – James were honored with awards orlectureships at the Alliance for Clinical Trials in Oncology annual meeting in Chicago:
 
Richard Goldberg, MD, a gastrointestinal oncologist and physician-in-chief, presented "Meaningful Outcomes: Lives Saved Due To Clinical Trials in Early-Stage Colon Cancer "as the first Charles G. Moertel Lecture, which was held during the plenary session of the Alliance’s meeting. It was the first Moertel lecture given through the newly formed Alliance, a cooperative group created by merging the North Central Cancer Treatment Group (NCCTG), Cancer and Leukemia Group B (CALGB) and the American College of Surgeons Oncology Group. This clinical research entity is sponsored by the National Cancer Institute. NCCTG initiated the lectureship in 1995 and transferred it to the Alliance after the merger.

http://cancer.osu.edu/about/publications/frontiers/archive/2012/07/19/of-note-7.aspx




Clara D. Bloomfield, MD, a Distinguished University Professor who also serves as cancer scholar and senior adviser to the OSUCCC – James, received the 2012Richard L. Schilsky Cancer and Leukemia Group B (CALGB) Achievement Award. The award, which acknowledges individual contributions to cooperative group research, is presented annually during the plenary session of the Alliance Group Meeting, where Bloomfield presented a summary of her research done in collaboration with CALGB. In the past 20 years, Bloomfield and colleagues have conducted pioneering research on molecular changes in the approximately 45 percent of acute myeloid leukemia patients with cytogenetically normal chromosomes. Most of her talk focused on this work. 

http://cancer.osu.edu/about/publications/frontiers/archive/2012/07/19/of-note-7.aspx



Electra Paskett, PhD, MSPH, associate director for population sciences at the OSUCCC – James, presented the 12th annual Jimmie Holland Lecture. Paskett, who also leads the Cancer Control Program at the OSUCCC – James, presented "Interventions to Address Cancer Health Disparities: The Case of Cervical Cancer in Appalachia.” She discussed methods to eliminate cancer health disparities, including community-based participatory research with transdisciplinary teams using multilevel interventions. She also reviewed past and current research projects in Ohio State's Center for Population Health and Health Disparities that she leads in Appalachia Ohio.

http://cancer.osu.edu/mediaroom/releases/Pages/Paskett-Presents-Jimmie-Holland-Lecture-at-National-Alliance-Meeting.aspx


The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu